Rep. Matsui Introduces Bipartisan Legislation to Support Access to Evidence-Based Care for Rare Disease Patients
Congresswoman
Over 90% of rare diseases have no FDA-approved treatment, leaving many rare and ultra-rare disease patients facing serious and life-threatening illness to rely on off-label use of drugs approved by the FDA for more common conditions. In addition to the FDA-approved label, this legislation will allow Medicare and Medicaid to use additional sources including compendia, peer-reviewed literature and the opinion of rare disease experts to meet medically accepted criteria that ensure coverage for rare disease treatment. It will also require private payers to create an expedited review pathway for formulary exception, reconsideration, and/or appeal of any denial of coverage for a drug or biological prescribed for a patient with a rare disorder.
"Access to the best medical care is crucial for patients living with rare and ultra-rare diseases, and too often these patients cannot get the evidence-based care they need," said
"Constituents have told me that expanding access to treatment for rare diseases is going to make a big difference for patients in our district and nationwide," said
"Modern medicine has the potential to address many of the most serious diseases we face, but too often people with rare and ultra-rare diseases don't have the opportunity to benefit from these new cures," said
"Rare conditions are labeled 'rare' for that very reason - that there are indeed so few patients with these conditions, that as a result they are forced to seek alternative treatments aside from those deemed 'standard,'" said
Patients, as well as health care providers, physicians, and non-profit organizations, are applauding the introduction of this legislation that will have a huge impact on their daily lives.
"Although there is only one FDA approved therapy for my rare condition, pemphigus, there are several other off-label drugs that are used as standard of care for patients like me," said
"We look forward to the enactment of this important legislation so that our community of rare patients can get the treatments their providers think best for them," said


Rep. Trone Hosts 'Trone Talk' on Open Enrollment for Medicare & Marketplace Insurance
Michigan Announces $3B In Refunds For Drivers
Advisor News
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
More Advisor NewsAnnuity News
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
More Annuity NewsHealth/Employee Benefits News
- Best’s Special Report: Rising Costs Could Offset AI-Driven Efficiency Gains at US Health Insurers
- Free Medicare counseling provided through LTADD
- Illinois consumers see higher prices and fewer choices for Obamacare health insurance
- COMPREHENSIVE REGULATIONS TO UNCOVER SUSPICIOUS HEALTHCARE (CRUSH) PROPOSED RULE (CMS-6098-P)
- CMS CRUSH PROPOSED RULE AIMS TO REAP NEARLY $90 BILLION FOR TAXPAYERS IN SAVINGS BY TARGETING FRAUD ACROSS MEDICARE, MEDICAID/CHIP, AND THE MARKETPLACE
More Health/Employee Benefits NewsLife Insurance News
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
More Life Insurance News